Pioneering And Innovative Research Into The Neurochemical Basis Of Substance Addiction

Main Category: Alcohol / Addiction / Illegal Drugs
Also Included In: Neurology / Neuroscience;  Smoking / Quit Smoking
Article Date: 24 Sep 2009 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 and a half stars

4.5 (2 votes)

Healthcare Prof:3 stars

3 (1 votes)


The European College of Neuropsychopharmacology (ECNP) is pleased to announce Jean-Pol Tassin as the recipient of the 2009 ECNP Neuropsychopharmacology Award in Basic Science Research in recognition of his pioneering and innovative research into the neurochemical basis of substance addiction.

The ECNP Neuropsychopharmacology Award recognises outstanding research in the field of neuropsychopharmacology and its closely related disciplines. Granted annually, the award alternates between basic science and clinical research and is accompanied by a prize of EUR 20,000. Jean-Pol Tassin Tassin is the award's 31st recipient.

Jean-Pol Tassin, currently team leader at the Collège de France's Molecular Genetic, Neurophysiology and Behaviour Laboratory in Paris, was drawn to addiction by his early research on nerve terminals in the prefrontal cortex and the effects of stress and long-term isolation on the meso-cortical pathway. Moving to studies on the impact of psychostimulants on cortical and sub-cortical neurons, his critical insight was to connect the disruption of nonadrenaline and serotonin neuron interaction with addictive behaviour. Jean-Pol Tassin's research showed how these neurons, when exposed to repeated psychostimulant abuse, become 'uncoupled,' thereby inducing distress, or withdrawal, for which further administrations of the drug are needed to achieve relief. Later refinements to this groundbreaking model have highlighted the key role played in tobacco addiction by monoamine inhibitors present in cigarettes.

Presenting the award at the 22nd ECNP Congress in Istanbul, the chairman of the ECNP Award Jury 2009, Tomas Hökfelt of the Karolinska Institute in Stockholm, commended Tassin's scientific originality as well as his landmark contribution to our understanding of this critical public health concern.

Jean-Pol Tassin's plenary lecture at the 22nd ECNP Congress has been recorded and is published on the ECNP website, http://www.ecnp.eu

Source:
Sonja Mak
European College of Neuropsychopharmacology

Article adapted by Medical News Today from original press release.
Visit our alcohol / addiction / illegal drugs section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Sonja Mak. "Pioneering And Innovative Research Into The Neurochemical Basis Of Substance Addiction." Medical News Today. MediLexicon, Intl., 24 Sep. 2009. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/164985.php>

APA
Sonja Mak. (2009, September 24). "Pioneering And Innovative Research Into The Neurochemical Basis Of Substance Addiction." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/164985.php.

Please note: If no author information is provided, the source is cited instead.


Alcohol / Addiction / Illegal Drugs

What Is a Hangover?

A hangover is a collection of signs and symptoms linked to a recent bout of heavy drinking. The sufferer typically has a headache, feels sick, dizzy, sleepy, confused and thirsty. Read more...

What is Addiction?

People with an addiction do not have control over what they are doing, taking or using. Their addiction may reach a point at which it is harmful. Addictions do not only include physical things we consume, such as drugs or alcohol, but may include... Read more...

Most Popular Articles



Follow Our Alcohol News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Alcohol / Addiction / Illegal Drugs Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »